Sector & Market
Ani Pharmaceuticals CFO Sells $285k Stock
CFO Stephen Carey exercised 3,313 options at $49.51 and sold them for $284,918 on July 2, 2026 via a Rule 10b5‑1 plan.
The sale generated $284,918, while the option exercise cost $164,026, leaving a p
